Workflow
TGS Commences Ultra-High Resolution 3D Seismic Survey for Green Volt Wind Development
GlobeNewswire· 2025-06-06 05:00
London, United Kingdom (06 June 2025) – TGS, a leading global provider of energy data and intelligence has commenced a geophysical survey for the pioneering Green Volt floating offshore wind farm. Mobilization initiated in Aberdeen last week and the work scheduled throughout June will include an ultra-high resolution 3D (UHR3D) seismic survey used to deliver detailed subsurface data for the floating wind farm’s site characterization. The Green Volt project is a joint venture between leading offshore wind d ...
Idorsia publishes invitations to bondholder meetings
GlobeNewswire· 2025-06-06 05:00
Ad hoc announcement pursuant to Art. 53 LR Bondholder meetings will take place on Wednesday, June 25, 2025, to vote on proposals to amend the terms of the two outstanding convertible bonds CB 2025 and CB 2028 Allschwil, Switzerland – June 6, 2025Idorsia Ltd (SIX: IDIA) today announced that following the expiry of the appeal period for the amended terms approved at the CB 2025 bondholder meeting of February 25, 2025 – during which no appeal was filed – it has published invitations to the next bondholder mee ...
Dassault Systèmes: Doubling EPS by 2029, 3D UNIV+RSES creating new growth opportunities
GlobeNewswire· 2025-06-06 05:00
Press ReleaseVELIZY-VILLACOUBLAY — June 6, 2025 Dassault Systèmes: Doubling EPS by 2029,3D UNIV+RSES creating new growth opportunities Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) hosts its 2025 Capital Markets Day at its headquarters in Vélizy-Villacoublay, France, today, June 6, 2025. The event, dedicated to financial analysts and investors, features a series of presentations by the Company’s executive management. It highlights how 3D UNIV+RSES mark a fundamental shift, providing the next gene ...
Addex GABAB PAM Candidate Demonstrates Robust Anti-Tussive Activity in Multiple Chronic Cough Preclinical Models
GlobeNewswire· 2025-06-06 05:00
Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, June 6, 2025 - Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders, announced today robust anti-tussive activity of its novel gamma-aminobutyric acid sub-type B receptor (GABAB) positive allosteric modulator (PAM) in multiple preclinical models of chronic cough compared to reference drugs. Some of ...
Silynxcom Secures $140,000 Order from Asia-Pacific Special Forces for Advanced In-Ear Communication Systems
GlobeNewswire· 2025-06-05 13:05
Core Viewpoint - Silynxcom Ltd. has received a $140,000 purchase order from a special forces unit in the Asia-Pacific region, highlighting the company's expanding global presence and the increasing demand for its advanced communication solutions among elite military units [1][2]. Group 1: Company Overview - Silynxcom Ltd. specializes in the development and manufacturing of ruggedized tactical communication headset devices, which are field-tested and combat-proven [5]. - The company's in-ear headset systems are recognized for their durability, advanced technology, and critical in-ear sound protection, making them a preferred choice for defense organizations [2][5]. - Silynxcom's products are designed to meet the rigorous demands of elite military operations, enhancing operational effectiveness and safety through features like "talking from the ear" and environmental hearing [3][5]. Group 2: Recent Developments - The recent order from a prestigious special forces unit is seen as a testament to the reliability and effectiveness of Silynxcom's communication systems [3]. - The company has secured recent orders from elite units in various regions, including the Israel Defense Forces and European special forces units, further strengthening its position in the specialized tactical communications market [4]. Group 3: Product Features - Silynxcom's in-ear communication systems incorporate proprietary technology that allows for clear communication while protecting users' hearing in high-noise environments [3]. - The in-ear headsets provide 360° situational awareness by eliminating unsafe sounds while maintaining ambient environmental awareness [5].
Outset Medical to Present at the Goldman Sachs 46th Annual Global Healthcare Conference
GlobeNewswire· 2025-06-05 13:05
Company Overview - Outset Medical, Inc. is a medical technology company focused on pioneering technology to reduce the cost and complexity of dialysis [3] - The Tablo® Hemodialysis System is FDA cleared for use from the hospital to the home, representing a significant technological advancement in dialysis [3] - Tablo serves as a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere, and by anyone [3] Product Features - The integration of water purification and on-demand dialysate production enables Tablo to function as a "dialysis clinic on wheels" [3] - Tablo features 2-way wireless data transmission and a proprietary data analytics platform, promoting a holistic approach to dialysis care [3] Upcoming Events - Management will present at the Goldman Sachs 46th Annual Healthcare Conference on June 11, 2025, at 11:20 a.m. Eastern time [1] - A live and archived webcast of the presentation will be available on the "Investors" section of the Outset website [2]
Zefiro Appoints Catherine Flax as its Interim Chief Executive Officer
GlobeNewswire· 2025-06-05 12:59
Core Viewpoint - Zefiro Methane Corp. has appointed Catherine Flax as Interim Chief Executive Officer, bringing extensive experience in investment banking and a commitment to leading the company in the evolving energy sector [2][5][6]. Company Overview - Zefiro Methane Corp. specializes in methane abatement and aims to be a significant player in the Active Sustainability movement, focusing on cleaning up air, land, and water sources affected by methane leaks [9]. - The company is recognized as North America's largest single plugger of wells and an originator of high-quality carbon offsets [1]. Leadership Background - Catherine Flax has a notable background, having served as Head of Commodity Derivatives (Americas) at BNP Paribas and CEO of Commodities EMEA at J.P. Morgan. She was named the Most Influential Woman in European Investment Banking in 2012 [3]. - Flax is also involved with the Securities Industry and Financial Markets Association (SIFMA) and serves on the board of the Independent System Operator for the New England Transmission grid [3]. Recent Activities - In 2025, Flax has been active in promoting Zefiro's initiatives, including speaking engagements and media appearances related to investment in alternative energy sources [4]. - The appointment of Flax follows the departure of Talal Debs, the previous CEO, who was recognized for his contributions as the company's founder [5]. Strategic Vision - Flax expressed a commitment to leading Zefiro through a period of growth and opportunity in the U.S. energy and resource sectors, emphasizing the company's readiness to adapt to technological and regulatory changes [6]. - The company aims to build the largest oilfield decommissioning business in North America while producing high-quality carbon offsets in the voluntary market [8].
LPL Financial Welcomes Loomis Wealth Management
GlobeNewswire· 2025-06-05 12:55
Core Insights - LPL Financial LLC has welcomed Loomis Wealth Management, which manages approximately $180 million in advisory, brokerage, and retirement plan assets, to its platforms [1][6][8] Group 1: Company Overview - Loomis Wealth Management was founded in 2010 by Bill and Curt Loomis, focusing on comprehensive, fiduciary-driven wealth management [2] - The team has a combined six decades of experience in the financial industry and is known for a holistic approach to wealth management in the Shenandoah Valley [2] - Justin K. Hitt joined the team in 2023, bringing a decade of educational experience before transitioning to finance [2] Group 2: Client Engagement and Services - The Loomis Wealth Management team emphasizes understanding clients' lifestyles, families, and financial aspirations to tailor investment portfolios [3] - They offer a full range of services including investment management, financial planning, and risk management [2][3] Group 3: Partnership with LPL Financial - The team sought to join LPL for greater autonomy, improved technology, and an enhanced client experience [3][4] - LPL Financial is recognized for its investment in resources that support advisors in delivering superior client experiences [4] - LPL supports nearly 29,000 financial advisors and manages approximately $1.8 trillion in brokerage and advisory assets [6]
VERSES® Announces Major Global Investment Firm Upgrades to Genius™ Enterprise Based on Early Project Success
GlobeNewswire· 2025-06-05 12:54
Core Insights - VERSES AI Inc. has transitioned a major global investment firm from the Genius beta program to an enterprise contract, indicating strong confidence in the product's potential [1][2][3] - The enterprise license allows for unlimited inferences and includes future provisions for outcome-based pricing after an initial fixed payment period [2] - Genius utilizes active inference models suitable for complex reasoning, positioning itself as an alternative to current AI technologies [2] Company Overview - VERSES AI Inc. specializes in cognitive computing and aims to develop next-generation intelligent software systems inspired by natural principles [3] - The flagship product, Genius, is designed to provide reliable domain-specific predictions and decisions under uncertainty, leveraging scientific principles from various fields [3]
SELLAS Life Sciences Expands Scientific Advisory Board with Addition of Two World-Renowned Hematology and Oncology Experts
GlobeNewswire· 2025-06-05 12:45
New appointments of Drs. Philip C. Amrein and Alex Kentsis Validate Lead Galinpepimut-S and SLS009 Programs as Company Approaches Key Inflection Points This YearNEW YORK, June 05, 2025 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’ or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, today announced the appointment of two distinguished oncology leaders to its Scientific Advisor ...